F.D.A. Actos Update

Posted on Saturday, September 17th, 2011 at 8:19 pm    

In June, the FDA published this FDA Drug Safety Communication related to the use of the drug Actos and Actos Combinations.  In the Communication, the FDA stated the following: “The U.S. Food and Drug Administration (FDA) is informing the public that use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with […]